MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ymthe.2024.01.034

Медицинская библиотека · Molecular therapy : the journal of the American Society of Gene Therapy · 2024

An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II.

Das Sabyasachi, Rruga Fatlum, Montepeloso Annita, Dimartino Agnese, Spadini Silvia, Corre Guillaume, Patel Janki, Cavalca Eleonora, Ferro Francesca, Gatti Alessandra, Milazzo Rita, Galy Anne, Politi Letterio S, Rizzardi Gian Paolo, Vallanti Giuliana, Poletti Valentina, Biffi Alessandra

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Mucopolysaccharidosis type II (MPS II), or Hunter syndrome, is a rare X-linked recessive lysosomal storage disorder due to a mutation in the lysosomal enzyme iduronate-2-sulfatase (IDS) gene. IDS deficiency leads to a progressive, multisystem accumulation of glycosaminoglycans (GAGs) and results in central nervous system (CNS) manifestations in the severe form. We developed up to clinical readiness a new hematopoietic stem cell (HSC) gene therapy approach for MPS II that benefits from a novel highly effective transduction protocol. We first provided proof of concept of efficacy of our approach aimed at enhanced IDS enzyme delivery to the CNS in a murine study of immediate translational value, employing a lentiviral vector (LV) encoding a codon-optimized human IDS cDNA. Then the therapeutic LV was tested for its ability to efficiently and safely transduce bona fide human HSCs in clinically relevant conditions according to a standard vs. a novel protocol that demonstrated superior ability to transduce bona fide long-term repopulating HSCs. Overall, these results provide strong proof of concept for the clinical translation of this approach for the treatment of Hunter syndrome.

Для цитирования: Das Sabyasachi, Rruga Fatlum, Montepeloso Annita, Dimartino Agnese, Spadini Silvia, Corre Guillaume, Patel Janki, Cavalca Eleonora, Ferro Francesca, Gatti Alessandra, Milazzo Rita, Galy Anne, Politi Letterio S, Rizzardi Gian Paolo, Vallanti Giuliana, Poletti Valentina, Biffi Alessandra. An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II.. Molecular therapy : the journal of the American Society of Gene Therapy. 2024. DOI: 10.1016/j.ymthe.2024.01.034.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.